Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 388 of 1,261
  1. US 10822599

    Compositions for linking DNA-binding domains and cleavage domains

    Sangamo Therapeutics, Inc. · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted
  2. US 10822337

    TGF-β inhibitorC

    Rigel Pharmaceuticals, Inc. · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted
  3. US 10822301

    3-carbon substituted 4-aminocyclopent-1-ene-1-carboxylic acid compounds as inhibitors of gamma-aminobutyric acid (GABA) aminotransferase

    Northwestern University · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted
  4. US 10821190

    HIV peptide vaults and methods of making and using thereof

    The Regents of the University of California · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted
  5. US 10821186

    Lipids and compositions for the delivery of therapeutics

    ARBUTUS BIOPHARMA CORPORATION · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted
  6. US 10821163

    Process for the production of a DNA vaccine for cancer immunotherapy

    Vaximm AG · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted
  7. US 10821149

    Composition and the use thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted
  8. US 10821182

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted
  9. US 10821078

    Nanostructure enhanced targeting (NSET) of inflammatory cells

    Northwestern University · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted
  10. US 10821181

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted
  11. US 10821134

    BK virus specific T cells

    The Board of Regents of the University of Texas System · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted
  12. US 10821074

    Sublingual and buccal film compositions

    Aquestive Therapeutics, Inc. · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted
  13. US 10821117

    Estrogen therapy for brain gray matter atrophy and associated disability

    The Regents of the University of California · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted
  14. US 10822608

    Oligonucleotide analogues targeting human LMNA

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted
  15. US 10822588

    Agents and methods to elicit anti-tumor immune response

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted
  16. US 10822426

    Humanized anti-CD73 antibodies

    Corvus Pharmaceuticals, Inc. · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted
  17. US 10822429

    Etanercept formulations exhibiting marked reduction in sub-visible particles

    Coherus BioSciences, Inc. · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted
  18. US 10822585

    Compositions and methods for treating retinal diseases

    The Regents of the University of California · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted
  19. US 10822414

    Anti-PD-1 antibodies, compositions comprising anti-PD-1 antibodies and methods of using anti-PD-1 antibodies

    Sutro Biopharma, Inc. · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted
  20. US 2020339710

    GLYCOPHOSPHOLIPID POLYMERIC NETWORK AND USE THEREOF

    BAUSCH & LOMB [US] · Granted Oct 29, 2020 · Expires Oct 24, 2040

    granted
  21. EP 3728594

    MATERIALIEN UND VERFAHREN ZUR BEHANDLUNG DES USHER-SYNDROMS TYP 2A

    CRISPR THERAPEUTICS AG [CH] · Granted Oct 28, 2020 · Expires Oct 23, 2040

    granted
  22. US 10813956

    Methods for making and using antimicrobial peptides

    Regents of the University of Minnesota · Granted Oct 27, 2020 · Expires Oct 22, 2040

    granted
  23. US 10815239

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Oct 27, 2020 · Expires Oct 22, 2040

    granted
  24. US 10814013

    Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications

    The Board of Regents of the University of Texas System · Granted Oct 27, 2020 · Expires Oct 22, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.